Diaceutics PLC - UK testing laboratories company - Wins five-year contract worth at least $1 million with an unnamed ‘top 30 global’ pharmaceutical company, in a multi-product subscription for customised data insights via its DXRX platform. Contract expands existing relationship with the company, and sets stage for future opportunities, it says. Says its offering of customised biomarket test results and interpretation was a key draw for the client, with the client's needs in oncology to be served by DXRX Signal.
Current stock price: 122.00 pence
12-month change: down 2.8%
Copyright 2022 Alliance News Limited. All Rights Reserved.